Literature DB >> 3289586

High-cell density fermentation studies of recombinant Escherichia coli strains expressing human interleukin-1 beta.

G Jung1, P Denèfle, J Becquart, J F Mayaux.   

Abstract

A high-productivity process has been developed for the production of mature human interleukin-1 beta (IL-1 beta) from recombinant Escherichia coli strains. Conditions were found that allow high IL-1 beta expression levels in high cell density cultures. Improved fed-batch fermentation strategies are described which include maintenance of glucose and acetate concentrations below 1 g/l and sparging the fermentor with an O2-enriched air supply. Using the E. coli tryptophan promoter control of transcription, a 2.2 g/l production level of IL-1 beta was achieved in E. coli B at cell densities of 55 g dry weight per litre. Another genetic construction involving the bacteriophage lambda cIts-PR expression cassette allowed a similar IL-1 beta production level (1.9 g/l) in E. coli E103S, albeit at a lower cell density (30 g/l). A simplified procedure allowing the purification of fully active IL-1 beta is also presented.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3289586     DOI: 10.1016/0769-2609(88)90100-7

Source DB:  PubMed          Journal:  Ann Inst Pasteur Microbiol        ISSN: 0769-2609


  10 in total

1.  Purification, cloning, and primary structure of an enantiomer-selective amidase from Brevibacterium sp. strain R312: structural evidence for genetic coupling with nitrile hydratase.

Authors:  J F Mayaux; E Cerebelaud; F Soubrier; D Faucher; D Pétré
Journal:  J Bacteriol       Date:  1990-12       Impact factor: 3.490

2.  Effects of medium quality on the expression of human interleukin-2 at high cell density in fermentor cultures of Escherichia coli K-12.

Authors:  H L MacDonald; J O Neway
Journal:  Appl Environ Microbiol       Date:  1990-03       Impact factor: 4.792

3.  A novel fed-batch based cultivation method provides high cell-density and improves yield of soluble recombinant proteins in shaken cultures.

Authors:  Mirja Krause; Kaisa Ukkonen; Tatu Haataja; Maria Ruottinen; Tuomo Glumoff; Antje Neubauer; Peter Neubauer; Antti Vasala
Journal:  Microb Cell Fact       Date:  2010-02-19       Impact factor: 5.328

4.  Purification, cloning, and primary structure of a new enantiomer-selective amidase from a Rhodococcus strain: structural evidence for a conserved genetic coupling with nitrile hydratase.

Authors:  J F Mayaux; E Cerbelaud; F Soubrier; P Yeh; F Blanche; D Pétré
Journal:  J Bacteriol       Date:  1991-11       Impact factor: 3.490

5.  Glucose and acetate influences on the behavior of the recombinant strain Escherichia coli HB 101 (GAPDH).

Authors:  A Gschaedler; N Thi Le; J Boudrant
Journal:  J Ind Microbiol       Date:  1994-07

6.  Studies on the production of human parathyroid hormone by recombinant Escherichia coli.

Authors:  M P Harder; E A Sanders; E Wingender; W D Deckwer
Journal:  Appl Microbiol Biotechnol       Date:  1993-06       Impact factor: 4.813

7.  Maximizing the expression of a recombinant gene in Escherichia coli by manipulation of induction time using lactose as inducer.

Authors:  P Neubauer; K Hofmann; O Holst; B Mattiasson; P Kruschke
Journal:  Appl Microbiol Biotechnol       Date:  1992-03       Impact factor: 4.813

8.  High cell density fermentation of recombinant Escherichia coli expressing human interferon alpha 1.

Authors:  D Riesenberg; K Menzel; V Schulz; K Schumann; G Veith; G Zuber; W A Knorre
Journal:  Appl Microbiol Biotechnol       Date:  1990-10       Impact factor: 4.813

9.  Kinetic studies of recombinant human interferon-gamma expression in continuous cultures of E. coli.

Authors:  S Thangminlal Vaiphei; Gaurav Pandey; K J Mukherjee
Journal:  J Ind Microbiol Biotechnol       Date:  2009-08-30       Impact factor: 3.346

10.  Implementation of a high cell density fed-batch for heterologous production of active [NiFe]-hydrogenase in Escherichia coli bioreactor cultivations.

Authors:  Qin Fan; Saskia Waldburger; Peter Neubauer; Sebastian L Riedel; Matthias Gimpel
Journal:  Microb Cell Fact       Date:  2022-09-19       Impact factor: 6.352

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.